According to GlobalData’s medical device pipeline database, 25 Retractors devices are in various stages of development globally. GlobalData’s report Retractors provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, six are in active development, while the remaining 19 are in an inactive stage of development. There are five products in the early stages of development, and the remaining one is in the late stages of development.

General Surgery Devices market covers wide-ranging devices used in diagnostic and surgical procedures primarily for the gastrointestinal tract, abdomen, and pelvis. A retractor is a surgical instrument used to separate the edges of a surgical incision or wound or to hold away certain organs and tissues (i.e. to provide tissue retraction) so that body parts underneath may be accessed during surgical operations. They are simple steel tool possessing a curved, hooked, or angled blade, which is manually manipulated to help maintain a desired position of tissue during surgery.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Retractors pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Retractors devices. Overall, most of these Retractors pipeline devices are being developed by private entities.

Key players involved in the active development of Retractors include University of California San Francisco, University of Pittsburgh, University of Saskatchewan, W.O.M. World of Medicine, Washington University in St Louis, University of Michigan, Air Force Medical Service, Asensus Surgical, Boston Scientific and Central Manchester University Hospitals NHS Foundation Trust.

For a complete picture of the developmental pipeline for Retractors devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.